Idorsia is a leading biopharmaceutical company that aims to discover, develop, and commercialize innovative medicines to help more patients. With a strong scientific core, we have more ideas, see more opportunities, and are dedicated to transforming the therapeutic landscape. Headquartered in Switzerland, a biotech-hub of Europe, we specialize in the discovery, development, and commercialization of innovative small molecules.

Our goal is to transform the horizon of therapeutic options and provide effective solutions for various target diseases. Our team of highly qualified professionals is passionate about pushing boundaries and achieving new breakthroughs. We have a robust clinical development pipeline and a commitment to innovation.

Idorsia focuses on innovative novel medicines and is courageous in testing novel concepts. We invite you to explore our website to learn more about our strategy, clinical development pipeline, and the story of how Idorsia came to be. Join us on our journey to make a meaningful difference in the lives of patients around the world